KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation

被引:16
作者
Bentz, Gretchen L. [1 ]
Bheda-Malge, Anjali [1 ]
Wang, Ling [1 ]
Shackelford, Julia [1 ,4 ]
Damania, Blossom [1 ,2 ,3 ]
Pagano, Joseph S. [1 ,2 ,3 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA
[4] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA
关键词
KSHV; LANA; EBV; LMP1; UCH-L1; EPSTEIN-BARR-VIRUS; PRIMARY EFFUSION LYMPHOMA; TERMINAL HYDROLASE L1; MEMBRANE-PROTEIN; UBIQUITIN-SPECIFIC PROTEASE; NUCLEAR ANTIGEN; GENE-EXPRESSION; CELL-LINES; DEGRADATION; SYSTEM;
D O I
10.1016/j.virol.2013.10.018
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ubiquitin C-terminal Hydrolase L1 (UCH-L1) has oncogenic properties and is highly expressed during malignancies. We recently documented that Epstein-Barr virus (EBV) infection induces uch-l1 expression. Here we show that Kaposi's Sarcoma-associated herpesvirus (KSHV) infection induced UCH-L1 expression, via cooperation of KSHV Latency-Associated Nuclear Antigen (LANA) and RBP-J kappa and activation of the uch-l1 promoter. UCH-L1 expression was also increased in Primary Effusion Lymphoma (PEL) cells co-infected with KSHV and EBV compared with PEL cells infected only with KSHV, suggesting EBV augments the effect of LANA on uch-l1. EBV latent membrane protein 1 (LMP1) is one of the few EBV products expressed in PEL cells. Results showed that LMP1 was sufficient to induce uch-l1 expression, and co-expression of LMP1 and LANA had an additive effect on uch-l1 expression. These results indicate that viral latency products of both human gamma-herpesviruses contribute to uch-l1 expression, which may contribute to the progression of lymphoid malignancies. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 60 条
[1]  
Ballestas ME, 2011, FUTURE MICROBIOL, V6, P1399, DOI [10.2217/fmb.11.137, 10.2217/FMB.11.137]
[2]   The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton [J].
Basseres, Eugenie ;
Coppotelli, Giuseppe ;
Pfirrmann, Thorsten ;
Andersen, Jens B. ;
Masucci, Maria ;
Frisan, Teresa .
CELLULAR MICROBIOLOGY, 2010, 12 (11) :1622-1633
[3]   Epstein-Barr Virus Latent Membrane Protein 1 Regulates the Function of Interferon Regulatory Factor 7 by Inducing Its Sumoylation [J].
Bentz, Gretchen L. ;
Shackelford, Julia ;
Pagano, Joseph S. .
JOURNAL OF VIROLOGY, 2012, 86 (22) :12251-12261
[4]   Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9 [J].
Bentz, Gretchen L. ;
Whitehurst, Christopher B. ;
Pagano, Joseph S. .
JOURNAL OF VIROLOGY, 2011, 85 (19) :10144-10153
[5]   Ubiquitin-proteasome system and Parkinson's diseases [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
EXPERIMENTAL NEUROLOGY, 2005, 191 :S17-S27
[6]   PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells [J].
Bheda, Anjali ;
Yue, Wei ;
Gullapalli, Anuradha ;
Shackelford, Julia ;
Pagano, Joseph S. .
LEUKEMIA & LYMPHOMA, 2011, 52 (07) :1336-1347
[7]   Ubiquitin editing enzyme UCH L1 and microtubule dynamics Implication in mitosis [J].
Bheda, Anjali ;
Gullapalli, Anuradha ;
Caplow, Michael ;
Pagano, Joseph S. ;
Shackelford, Julia .
CELL CYCLE, 2010, 9 (05) :980-994
[8]   Expression and Functional Studies of Ubiquitin C-Terminal Hydrolase L1 Regulated Genes [J].
Bheda, Anjali ;
Shackelford, Julia ;
Pagano, Joseph S. .
PLOS ONE, 2009, 4 (08)
[9]   Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling [J].
Bheda, Anjali ;
Yue, Wei ;
Gullapalli, Anuradha ;
Whitehurst, Chris ;
Liu, Renshui ;
Pagano, Joseph S. ;
Shackelford, Julia .
PLOS ONE, 2009, 4 (06)
[10]   Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue [J].
Bornkamm, Georg W. .
SEMINARS IN CANCER BIOLOGY, 2009, 19 (06) :351-365